Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A prospective, multi centre, interventional, non-comparator, open label study to demonstrate the efficacy, safety, and performance of ConvaFoamâ„¢ Silicone, ConvaFoamâ„¢ Border and ConvaFoamâ„¢ Non-adhesive to protect against skin breakdown
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ConvaFoam Dressings | Experimental | All participants skin areas will be assessed and allocated a dressing based upon the investigator's clinical judgement. They will receive either ConvaFoam Border, Silicone or Non-Adhesive for up to 2 weeks as an addition to their standard pressure injury prevention protocol. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ConvaFoam | Device | ConvaFoamâ„¢ Silicone, ConvaFoamâ„¢ Border and ConvaFoamâ„¢ non-adhesive dressings are designed to provide a moist wound healing environment and removing dead-space between the wound and dressing interface. These dressings are designed to manage excess exudate levels which may further damage the wound bed and surrounding skin. In addition, the dressings are designed to protect fragile skin from moisture, shear, and friction damage. These will be used in line with the patients pressure injury mitigation protocol for a 2 week period, with daily inspections of the skin area. |
| Measure | Description | Time Frame |
|---|---|---|
| To measure the efficacy of ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ non-adhesive dressings when used to protect of skin against breakdown. | This will be measured by: • The incidence of skin breakdown | 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| To assess the safety of ConvaFoamâ„¢ Silicone, ConvaFoamâ„¢ Border and ConvaFoamâ„¢ non-adhesive dressings when used to protect skin against breakdown. | This will be measured via reporting all device related adverse events and device malfunctions, such as allergic reactions, bleeding, pain/discomfort in area of dressing, skin irritation, and reported as per protocol | 2 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| To assess the performance of ConvaFoamâ„¢ Silicone, ConvaFoamâ„¢ Border and ConvaFoamâ„¢ non-adhesive dressings when used to protect skin against breakdown. | This will be measured by reporting: The number of times the dressing has been lifted and reapplied before needing to be replaced compared to the instructions for use. The ability of the dressing to be reapplied to the skin following skin assessments as per the patients standard of care. | 2 weeks |